ATE460154T1 - Bioresorbierbare zusammensetzung mit kontrollierter freisetzung - Google Patents

Bioresorbierbare zusammensetzung mit kontrollierter freisetzung

Info

Publication number
ATE460154T1
ATE460154T1 AT07711943T AT07711943T ATE460154T1 AT E460154 T1 ATE460154 T1 AT E460154T1 AT 07711943 T AT07711943 T AT 07711943T AT 07711943 T AT07711943 T AT 07711943T AT E460154 T1 ATE460154 T1 AT E460154T1
Authority
AT
Austria
Prior art keywords
ceramic
pharmaceutical composition
preparation
controlled
controlled release
Prior art date
Application number
AT07711943T
Other languages
English (en)
Inventor
Niklas Axen
Hans Lennernaes
Original Assignee
Lidds Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lidds Ab filed Critical Lidds Ab
Application granted granted Critical
Publication of ATE460154T1 publication Critical patent/ATE460154T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1611—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682—Processes
    • A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT07711943T 2006-03-14 2007-03-14 Bioresorbierbare zusammensetzung mit kontrollierter freisetzung ATE460154T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA200600361 2006-03-14
PCT/EP2007/002250 WO2007104549A2 (en) 2006-03-14 2007-03-14 Bioresorbable controlled-release composition

Publications (1)

Publication Number Publication Date
ATE460154T1 true ATE460154T1 (de) 2010-03-15

Family

ID=36602790

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07711943T ATE460154T1 (de) 2006-03-14 2007-03-14 Bioresorbierbare zusammensetzung mit kontrollierter freisetzung

Country Status (17)

Country Link
US (1) US8999389B2 (de)
EP (1) EP1996160B8 (de)
JP (1) JP5216601B2 (de)
KR (1) KR101378174B1 (de)
CN (1) CN101431984B (de)
AT (1) ATE460154T1 (de)
AU (1) AU2007224651B8 (de)
CA (1) CA2644429C (de)
DE (1) DE602007005231D1 (de)
DK (1) DK1996160T3 (de)
ES (1) ES2342123T3 (de)
IL (1) IL193973A (de)
MX (1) MX2008011606A (de)
PL (1) PL1996160T3 (de)
RU (1) RU2405537C2 (de)
WO (1) WO2007104549A2 (de)
ZA (1) ZA200807881B (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL181834A (en) 2006-04-02 2011-04-28 Iscar Ltd Cutting head and adaptor
RU2536415C2 (ru) * 2008-11-27 2014-12-20 Лиддс Аб Применение карбоксиметилцеллюлозы для контроля выдавливаемости и времени затвердения композиций, содержащих один или более керамических материалов
JP2012517466A (ja) * 2009-02-12 2012-08-02 アドゥロ・マテリアル・アクチボラゲット 制御されたドラッグデリバリーのための生体分解性担体を含む組成物
ES2732308T3 (es) * 2013-12-23 2019-11-21 Bcn Peptides Sa Análogos de bicalutamida o (s)-bicalutamida como compuestos activadores de la exocitosis para su uso en el tratamiento de un desorden de acúmulo lisosomal o glucogenosis
EP3302423B1 (de) 2015-06-04 2022-05-25 Crititech, Inc. Partikelproduktionssystem und partikelsammelvorrichtung
WO2017176628A1 (en) 2016-04-04 2017-10-12 Crititech, Inc. Methods for solid tumor treatment
CA3038699A1 (en) 2016-10-17 2018-04-26 Lidds Ab Calcium sulphate hemihydrate production via controlled air flow
BR112019023948A2 (pt) 2017-06-09 2020-06-09 Crititech Inc tratamento de cistos epiteliais por injeção intracística de partículas antineoplásicas
EP3615004B1 (de) 2017-06-14 2025-02-19 Crititech, Inc. Verfahren zur behandlung von lungenerkrankungen
JP7792750B2 (ja) 2017-10-03 2025-12-26 クリティテック・インコーポレイテッド 癌の治療のための免疫療法剤の全身送達と組み合わせた抗腫瘍粒子の局所送達
RU2683255C1 (ru) * 2018-03-06 2019-03-27 Федеральное государственное бюджетное учреждение науки Институт химии твердого тела Уральского отделения Российской академии наук Биоактивный композиционный материал для замещения костных дефектов и способ его получения
WO2019170912A1 (en) 2018-03-09 2019-09-12 Lidds Ab Bioresorbable controlled-release compositions with sting modulating molecules

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3797758A (en) * 1972-06-16 1974-03-19 Giulini Gmbh Geb Method of producing finely dispersed alpha calcium sulfate hemihydrate
JP2702953B2 (ja) 1988-01-30 1998-01-26 オリンパス光学工業株式会社 薬液含浸セラミックス
EP0376331A3 (de) 1988-12-29 1991-03-13 Asahi Kogaku Kogyo Kabushiki Kaisha Granula zur langsamen Wirkstoffabgabe sowie Verfahren zu deren Herstellung
US5614206A (en) * 1995-03-07 1997-03-25 Wright Medical Technology, Inc. Controlled dissolution pellet containing calcium sulfate
US6132463A (en) 1995-05-19 2000-10-17 Etex Corporation Cell seeding of ceramic compositions
US8333996B2 (en) 1995-05-19 2012-12-18 Etex Corporation Calcium phosphate delivery vehicle and adjuvant
AU734691B2 (en) * 1996-10-16 2001-06-21 Life Science Enterprises, Inc. Bioceramic compositions
US6391336B1 (en) * 1997-09-22 2002-05-21 Royer Biomedical, Inc. Inorganic-polymer complexes for the controlled release of compounds including medicinals
SE9704400D0 (sv) * 1997-11-28 1997-11-28 Astra Ab Porous inorganic particles as carriers for drug substances
US6030635A (en) * 1998-02-27 2000-02-29 Musculoskeletal Transplant Foundation Malleable paste for filling bone defects
GB0020610D0 (en) 2000-08-21 2000-10-11 Dytech Corp Ltd Uses of porous carriers
US6730324B2 (en) * 2001-04-20 2004-05-04 The University Of British Columbia Biofunctional hydroxyapatite coatings and microspheres for in-situ drug encapsulation
SE522749C2 (sv) * 2002-03-04 2004-03-02 Cerbio Tech Ab Ytbeläggningsförfarande, ytbelagd anordning och biokompatibel ytbeläggning
US8124118B2 (en) * 2003-10-22 2012-02-28 Lidds Ab Composition comprising biodegradable hydrating ceramics for controlled drug delivery

Also Published As

Publication number Publication date
EP1996160B1 (de) 2010-03-10
JP2009529554A (ja) 2009-08-20
CN101431984B (zh) 2013-07-10
IL193973A (en) 2012-07-31
ES2342123T3 (es) 2010-07-01
US8999389B2 (en) 2015-04-07
MX2008011606A (es) 2008-09-22
PL1996160T3 (pl) 2010-09-30
DK1996160T3 (da) 2010-07-05
AU2007224651A1 (en) 2007-09-20
KR101378174B1 (ko) 2014-03-27
WO2007104549A8 (en) 2007-12-13
AU2007224651B2 (en) 2011-10-13
AU2007224651A8 (en) 2011-10-27
US20090118215A1 (en) 2009-05-07
HK1129061A1 (en) 2009-11-20
EP1996160A2 (de) 2008-12-03
RU2008140519A (ru) 2010-04-20
ZA200807881B (en) 2009-10-28
WO2007104549A2 (en) 2007-09-20
CA2644429A1 (en) 2007-09-20
DE602007005231D1 (de) 2010-04-22
RU2405537C2 (ru) 2010-12-10
JP5216601B2 (ja) 2013-06-19
CN101431984A (zh) 2009-05-13
KR20080108128A (ko) 2008-12-11
EP1996160B8 (de) 2010-05-12
WO2007104549A3 (en) 2007-11-08
IL193973A0 (en) 2009-09-22
CA2644429C (en) 2014-07-29
AU2007224651B8 (en) 2011-10-27

Similar Documents

Publication Publication Date Title
ATE460154T1 (de) Bioresorbierbare zusammensetzung mit kontrollierter freisetzung
WO2006044504A8 (en) Cgrp receptor antagonists
BRPI0910182B8 (pt) composto de fórmula (i), composição farmacêutica e uso de um composto
BRPI0715893A2 (pt) composto de azetidina e uso para a preparaÇço de um medicamento para a prevenÇço ou tratamento de distérbios distÍmicos ou do sono
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
WO2006099268A3 (en) Cgrp receptor antagonists
WO2006031610A3 (en) Bicyclic anilide spirolactam cgrp receptor antagonists
ATE482210T1 (de) Oxadiazolderivate als s1p1-rezeptor-agonisten
BRPI0509894A (pt) composições farmacêuticas compreendendo um amido anfifìlico
CY1112398T1 (el) Πυρρολιδινονες υποκατασταθεισες απο κυκλοεξυλιο ως αναστολεις της 11-β-υδροξυστεροειδικης αφυδρογονασης 1
WO2008112159A3 (en) Monocyclic anilide spirolactam cgrp receptor antagonists
EA200970377A1 (ru) Композиции фенилалкиламинокарбамата
CL2008003067A1 (es) Compuesto 2-[3-(2,2-difluoro-benzo[1,3]dioxol-5-ilamino)-5-(2,6-dimetil-piridin-4-il)-[1,2,4]triazol-1-il]-n-etil-acetamida, modulador de receptores nicotinicos alfa-7; proceso de preparacion; composicion farmaceutica y su proceso de preparacion; y su uso en el tratamiento de trastornos psicoticos, intelectuales, inflamatorios.
WO2006047196A3 (en) Cgrp receptor antagonists
MX2009003929A (es) Composiciones de fenilalquil carbamato.
WO2006031676A3 (en) Tricyclic anilide spirohydantoin cgrp receptor antagonists
WO2005115392A8 (en) 3-(4-heteroarylcyclohexylamino) cyclopentanecarboxamides as modulators of chemokine receptors
WO2006041830A3 (en) Cgrp receptor antagonists
BRPI0620566B8 (pt) composição, composição para o tratamento profilático ou terapêutico de fibrose miocardial ou uma condição associada, composição para o tratamento profilático ou terapêutico de hipertensão, uso de uma composição, uso de vip ou de um fragmento do mesmo e uso de um vip
WO2007072201A3 (en) 3-aminocyclopentanecarboxamides as modulators of chemokine receptors
WO2007061692A3 (en) Spirolactam tricyclic cgrp receptor antagonists
WO2006044449A3 (en) Cgrp receptor antagonists
CL2008002223A1 (es) Compuestos derivados de 9-desoxo-9a-metil-9a-aza-9a-homoeritromicina a 2'-o-sustituida; proceso de preparación; compuesto intermediario; composición farmacéutica; y su uso en el tratamiento y/o profilaxis de la malaria.
MX2007001992A (es) Antagonistas del receptor 5-ht7.
IL190850A (en) Use of Artemisinin and Derivatives to Prepare a Pharmacist and Insulin Composition Containing Local Compositions Containing Them

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties